Given that Chairman/CEO Frazier gave a very thoughtful, and yet candid presentation last week, it must be more than a little disappointing that Goldman kept its non-favored stance on the Whitehouse Station company:
. . . .Goldman, Sachs & Co. reiterates "Neutral" rating on Merck. . .
So it goes.

No comments:
Post a Comment